Dementia with Lewy bodies (DLB) is a neurodegenerative disorder with a wide heterogeneity of symptoms, which suggests the existence of different subtypes. We used data-driven analysis of magnetic resonance imaging (MRI) data to investigate DLB subtypes. We included 165 DLB from the Mayo Clinic and 3 centers from the European DLB consortium and performed a hierarchical cluster analysis to identify subtypes based on gray matter (GM) volumes. To characterize the subtypes, we used demographic and clinical data, as well as β-amyloid, tau, and cerebrovascular biomarkers at baseline, and cognitive decline over three years. We identified 3 subtypes: an older subtype with reduced cortical GM volumes, worse cognition, and faster cognitive decline (n = 49, 30%); a subtype with low GM volumes in fronto-occipital regions (n = 76, 46%); and a subtype of younger patients with the highest cortical GM volumes, proportionally lower GM volumes in basal ganglia and the highest frequency of cognitive fluctuations (n = 40, 24%). This study shows the existence of MRI subtypes in DLB, which may have implications for clinical workout, research, and therapeutic decisions.

Center for Age Related Medicine Stavanger University Hospital Stavanger Norway

Day Hospital of Geriatrics Memory Resource and Research Center of Strasbourg Department of Geriatrics Hopitaux Universitaires de Strasbourg Strasbourg France

Department of Electrical Engineering and Computer Science University of Stavanger Stavanger Norway

Department of Neuroimaging Center for Neuroimaging Sciences Institute of Psychiatry Psychology and Neuroscience Kings College London London UK

Department of Neurology and Alzheimer Center VU University Medical Center Amsterdam Netherlands

Department of Neurology Charles University 2nd Faculty of Medicine Motol University Hospital Prague Czech Republic

Department of Radiology Mayo Clinic Rochester MN US

Division of Clinical Geriatrics Center for Alzheimer Research Department of Neurobiology Care Sciences and Society Karolinska Institutet Stockholm Sweden

Institute of Biomedical Research August Pi i Sunyer Barcelona Spain

International Clinical Research Center St Annes University Hospital Brno Brno Czech Republic

Medical Psychology Unit Institute of Neurosciences University of Barcelona Barcelona Spain

Quantitative Health Sciences Mayo Clinic Rochester MN US

Stavanger Medical Imaging Laboratory Department of Radiology Stavanger University Hospital Stavanger Norway

UCL institutes of neurology and center for medical image computing London UK

University of Strasbourg and French National Center for Scientific Research ICONE Strasbourg France

Zobrazit více v PubMed

Abdelnour C, et al. The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies. NeuroImage Clin. 2020;27:102333. doi: 10.1016/j.nicl.2020.102333. PubMed DOI PMC

Ferreira D, et al. Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies. Neurobiol. Aging. 2021;105:252–261. doi: 10.1016/j.neurobiolaging.2021.04.029. PubMed DOI PMC

Ferreira, D. et al. Cross-sectional associations of amyloid-beta, tau, and cerebrovascular biomarkers with neurodegeneration in dementia with Lewy bodies. Neurology In-press, 10.1212/WNL.0000000000201579 (2022). PubMed PMC

Oppedal K, et al. A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium. Alzheimer’s Dement. 2019;15:400–409. doi: 10.1016/j.jalz.2018.09.011. PubMed DOI

Ferreira D, Nordberg A, Westman E. Biological subtypes of Alzheimer disease: A systematic review and meta-analysis. Neurology. 2020;94:436–448. doi: 10.1212/WNL.0000000000009058. PubMed DOI PMC

Kantarci K, et al. Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology. 2012;79:553–560. doi: 10.1212/WNL.0b013e31826357a5. PubMed DOI PMC

Ferreira D, et al. Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: Longitudinal trajectories and clinical applications. Sci. Rep. 2017;7:46263. doi: 10.1038/srep46263. PubMed DOI PMC

Habes M, et al. Disentangling Heterogeneity in Alzheimer’s Disease and Related Dementias Using Data-Driven Methods. Biol. Psychiatry. 2020;88:70–82. doi: 10.1016/j.biopsych.2020.01.016. PubMed DOI PMC

Uribe C, et al. Patterns of cortical thinning in nondemented Parkinson’s disease patients. Mov. Disord. 2016;31:699–708. doi: 10.1002/mds.26590. PubMed DOI PMC

Uribe C, et al. Cortical atrophy patterns in early Parkinson’s disease patients using hierarchical cluster analysis. Parkinsonism Relat. Disord. 2018;50:3–9. doi: 10.1016/j.parkreldis.2018.02.006. PubMed DOI

Inguanzo, A. et al. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’ s disease. Parkinsonism Relat Disord. 82,16–23 (2021). PubMed

Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I., Zimmerman, R. A. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am. J. Roentgenol. 8, 421–426 (1987). PubMed

Watson R, O’Brien JT, Barber R, Blamire AM. Patterns of gray matter atrophy in dementia with Lewy bodies: A voxel-based morphometry study. Int. Psychogeriatr. 2012;24:532–540. doi: 10.1017/S1041610211002171. PubMed DOI

Watson R, Colloby SJ, Blamire AM, O’Brien JT. Subcortical volume changes in dementia with Lewy bodies and Alzheimer’s disease. A comparison with healthy aging. Int. Psychogeriatr. 2016;28:529–536. doi: 10.1017/S1041610215001805. PubMed DOI

van der Zande JJ, et al. Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer’s disease pathology. Neurobiol. Aging. 2018;71:171–178. doi: 10.1016/j.neurobiolaging.2018.07.005. PubMed DOI

Botzung A, Philippi N, Noblet V, Loureiro De Sousa P, Blanc F. Pay attention to the basal ganglia: A volumetric study in early dementia with Lewy bodies. Alzheimer’s Res. Ther. 2019;11:108. doi: 10.1186/s13195-019-0568-y. PubMed DOI PMC

Ferguson LW, Rajput AH, Rajput A. Early-onset vs. Late-onset Parkinson’s disease: A Clinical-pathological Study. Can. J. Neurol. Sci. 2015;43:113–119. doi: 10.1017/cjn.2015.244. PubMed DOI

Murray ME, et al. Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: A retrospective study. Lancet Neurol. 2011;10:785–796. doi: 10.1016/S1474-4422(11)70156-9. PubMed DOI PMC

Na HK, et al. Malignant progression in parietal-dominant atrophy subtype of Alzheimer’s disease occurs independent of onset age. Neurobiol. Aging. 2016;47:149–156. doi: 10.1016/j.neurobiolaging.2016.08.001. PubMed DOI

Peraza LR, et al. FMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies. NeuroImage Clin. 2014;4:558–565. doi: 10.1016/j.nicl.2014.03.013. PubMed DOI PMC

Ferreira, D., Pereira, J. B., Volpe, G. & Westman, E. Subtypes of Alzheimer’s disease display distinct network abnormalities extending beyond their pattern of brain atrophy. Front. Neurol. 10, 1–10 (2019). PubMed PMC

Sanchez-Castaneda C, et al. Frontal and associative visual areas related to visual hallucinations in dementia with lewy bodies and Parkinson’s disease with dementia. Mov. Disord. 2010;25:615–622. doi: 10.1002/mds.22873. PubMed DOI

Pezzoli S, Cagnin A, Antonini A, Venneri A. Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease. Postgrad. Med. 2019;131:509–522. doi: 10.1080/00325481.2019.1656515. PubMed DOI

Blanc F, et al. Cortical thickness in dementia with Lewy bodies and Alzheimer’s disease: A comparison of prodromal and dementia stages. PLoS One. 2015;10:e0127396. doi: 10.1371/journal.pone.0127396. PubMed DOI PMC

McKeith IG, et al. Diagnosis and managment of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88–100. doi: 10.1212/WNL.0000000000004058. PubMed DOI PMC

Rolinski M, et al. Aberrant functional connectivity within the basal ganglia of patients with Parkinson’s disease. NeuroImage Clin. 2015;8:126–132. doi: 10.1016/j.nicl.2015.04.003. PubMed DOI PMC

Szewczyk-Krolikowski K, et al. Functional connectivity in the basal ganglia network differentiates PD patients from controls. Neurology. 2014;83:208–214. doi: 10.1212/WNL.0000000000000592. PubMed DOI PMC

Li R, et al. Basal ganglia atrophy–associated causal structural network degeneration in Parkinson’s disease. Hum. Brain Mapp. 2021;43:1145–1156. doi: 10.1002/hbm.25715. PubMed DOI PMC

Lowther ER, O’Brien JT, Firbank MJ, Blamire AM. Lewy body compared with Alzheimer dementia is associated with decreased functional connectivity in resting state networks. Psychiatry Res. 2014;223:192–201. doi: 10.1016/j.pscychresns.2014.06.004. PubMed DOI

Taylor JP, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19:157–169. doi: 10.1016/S1474-4422(19)30153-X. PubMed DOI PMC

Ferreira D, et al. β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies. Neurology. 2020;95:e3257–e3268. doi: 10.1212/WNL.0000000000010943. PubMed DOI PMC

Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20:68–80. doi: 10.1016/S1474-4422(20)30412-9. PubMed DOI PMC

Kantarci K, et al. β-Amyloid PET and neuropathology in dementia with Lewy bodies. Neurology. 2020;94:e282–e291. doi: 10.1212/WNL.0000000000008818. PubMed DOI PMC

Graff-Radford, et al. Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry. Mov. Disord. 2016;31:989–994. doi: 10.1002/mds.26666. PubMed DOI PMC

Elder GJ, et al. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies. Int. J. Geriatr. Psychiatry. 2017;32:1182–1189. doi: 10.1002/gps.4719. PubMed DOI PMC

Nedelska Z, et al. Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol. Aging. 2015;36:452–461. doi: 10.1016/j.neurobiolaging.2014.07.005. PubMed DOI PMC

Blanc F, et al. Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease. Alzheimer’s Res. Ther. 2016;8:31–41. doi: 10.1186/s13195-016-0198-6. PubMed DOI PMC

Poulakis K, et al. Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer’s disease. Nat Commun. 2022;13:4566. doi: 10.1038/s41467-022-32202-6. PubMed DOI PMC

Oppedal K, Borda MG, Ferreira D, Westman E, Aarsland D. European DLB consortium: diagnostic and prognostic biomarkers in dementia with Lewy bodies, a multicenter international initiative. Neurodegener. Dis. Manag. 2019;9:247–250. doi: 10.2217/nmt-2019-0016. PubMed DOI

McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology. 2005;65:1863–72. doi: 10.1212/01.wnl.0000187889.17253.b1. PubMed DOI

Kantarci K, et al. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann. Neurol. 2017;81:58–67. doi: 10.1002/ana.24825. PubMed DOI PMC

Muehlboeck JS, Westman E, Simmons A. TheHiveDB image data management and analysis framework. Front. Neuroinform. 2014;7:49. doi: 10.3389/fninf.2013.00049. PubMed DOI PMC

Breiman L. Random forests. Machine Learning. 2001;45:5–32. doi: 10.1023/A:1010933404324. DOI

Gray KR, Aljabar P, Heckemann RA, Hammers A, Rueckert D. Random forest-based similarity measures for multi-modal classification of Alzheimer’s disease. Neuroimage. 2013;65:167–175. doi: 10.1016/j.neuroimage.2012.09.065. PubMed DOI PMC

Poulakis K, et al. Heterogeneous patterns of brain atrophy in Alzheimer’s disease. Neurobiol. Aging. 2018;65:98–108. doi: 10.1016/j.neurobiolaging.2018.01.009. PubMed DOI

Cerebrovascular and Alzheimer's disease biomarkers in dementia with Lewy bodies and other dementias

Sex differences in brain atrophy in dementia with Lewy bodies